Adaptive Phage Therapeutics
Developing phage therapy treatments
- Pharma & life sciences
About Adaptive Phage Therapeutics
APT develops innovative therapies utilizing bacteriophages to combat multi-drug resistant infections, providing broad spectrum coverage where traditional antibiotics fail
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Gaithersburg, Maryland, United States
- Founded
- 2016
- Revenue
- $11.8M – $92.9MTamtam estimate
- Website
- aphage.com
Adaptive Phage Therapeutics at a glance
Adaptive Phage Therapeutics is a company in the Biotechnology industry, headquartered in Gaithersburg, Maryland, United States.
Adaptive Phage Therapeutics was founded in 2016.
Adaptive Phage Therapeutics has 11–50 employees.
Adaptive Phage Therapeutics's revenue is $11.8M – $92.9M (Tamtam estimate).
Frequently asked questions about Adaptive Phage Therapeutics
What is Adaptive Phage Therapeutics's revenue?
Tamtam estimates Adaptive Phage Therapeutics's annual revenue at $11.8M – $92.9M.
How many employees does Adaptive Phage Therapeutics have?
Adaptive Phage Therapeutics has 11–50 employees.
Where is Adaptive Phage Therapeutics headquartered?
Adaptive Phage Therapeutics is headquartered in Gaithersburg, Maryland, United States.
Selling to companies like Adaptive Phage Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies